Cord Blood Alkaline Phosphatase as A Predictive Biomarker for Neonatal Jaundice in Term and Near-Term Neonate
DOI:
https://doi.org/10.55489/ijmr.1303202583Keywords:
Neonatal Jaundice, Cord Blood, Alkaline Phosphatase, Hyperbilirubinemia, Hemolysis, ConsanguinityAbstract
Background: Neonatal hyperbilirubinemia (NNHB) is a common condition that can lead to severe neurological complications if untreated, particularly in resource-limited settings where early detection is challenging. This study evaluates cord blood alkaline phosphatase (ALP) as a non-invasive biomarker for predicting neonatal jaundice.
Methods: A prospective observational study was conducted with 95 healthy term and near-term neonates (>35 weeks gestation) at Krishna Hospital, Karad, India, from May 2023 to November 2024. Cord blood ALP levels were analyzed at birth, with clinical follow-up for jaundice over 7 days. Neonates with conditions affecting liver or hematopoiesis or hematopoiesis were excluded. Data on demographic, clinical, and laboratory parameters, including hemoglobin and bilirubin levels, were collected. Statistical analysis was performed using chi-square tests and t-tests to assess associations with jaundice.
Results: Of 95 neonates, 44 (46.3%) developed jaundice. Jaundiced neonates had significantly higher cord blood ALP (345 ± 85 IU/L vs. 141 ± 37 IU/L, P <0.001) and lower hemoglobin (14.5 ± 3.2 g/dL vs. 16.5 ± 3.0 g/dL, P < 0.001) compared to non-jaundiced neonates. Parental consanguinity was more prevalent in jaundiced neonates (25% vs. 9.8%, P = 0.048). No significant associations were found with gestational age, birth weight, or breastfeeding.
Conclusion: Elevated cord blood ALP is a promising biomarker for early identification of neonates at risk of jaundice, particularly in resource-constrained settings. Future multicenter studies are needed to validate ALP thresholds and explore genetic factors linked to consanguinity for improved NNHB management.
References
1. Ambalavanan N, Carlo WA. Jaundice and hyperbilirubinemia in the Newborn. In: Kliegman RM, Behrman RE, Stanton BF, Schor NF, St Geme III JW, eds. Nelson Textbook of Pediatrics. 20th ed. Philadelphia: Elsevier; 2015:871-872.
2. Watchko JF, Tiribelli C. Bilirubin-induced neurologic damage-mechanisms and management approaches. N Engl J Med. 2013;369(21):2021-2030. DOI: https://doi.org/10.1056/NEJMra1308124 PMid:24256380
3. Hamza A. Kernicterus. Autops Case Rep. 2019;9(1):e2018057. DOI: https://doi.org/10.4322/acr.2018.057 PMid:30863731 PMCid:PMC6394357
4. American Academy of Pediatrics. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics. 1994;94:558-565. DOI: https://doi.org/10.1542/peds.94.4.558
5. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316. DOI: https://doi.org/10.1542/peds.114.1.297 PMid:15231951
6. Gale R, Seidman DS, Stevenson DK. Hyperbilirubinemia and early discharge. J Perinatol. 2001;21(1):40-43. DOI: https://doi.org/10.1038/sj.jp.7200487 PMid:11268867
7. Tinnion RJ, Embleton ND. How to use alkaline phosphatase in neonatology. Arch Dis Child Educ Pract Ed. 2012;97:157-163. DOI: https://doi.org/10.1136/archdischild-2012-301633 PMid:22761487
8. Nalbantoglu A, Ovalı F, Nalbantoglu B. Alkaline phosphatase as an early marker of hemolysis in newborns. Pediatr Int. 2011;53:936-938. DOI: https://doi.org/10.1111/j.1442-200X.2011.03491.x PMid:22010794
9. Ahmadpour-Kacho M, Zahed Pasha Y, Haghshenas M, et al. Cord blood alkaline phosphatase as an indicator of neonatal jaundice. Iran J Pediatr. 2015;25(5):e718. DOI: https://doi.org/10.5812/ijp.718
10. Mitra S, Rennie J. Neonatal jaundice: aetiology, diagnosis and treatment. Br J Hosp Med (Lond). 2017;78(12):699-704. DOI: https://doi.org/10.12968/hmed.2017.78.12.699 PMid:29240507
11. Bhutani VK, Wong R. Bilirubin-induced neurologic dysfunction (BIND). Semin Fetal Neonatal Med. 2015;20(1):1. DOI: https://doi.org/10.1016/j.siny.2014.12.010 PMid:25577656
12. Ballard JL, Khoury JC, Wedig K, et al. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119(3):417-423. DOI: https://doi.org/10.1016/S0022-3476(05)82056-6 PMid:1880657
13. Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012;32(9):660-664. DOI: https://doi.org/10.1038/jp.2012.71 PMid:22678141
14. Cloherty JP, Eichenwald EC, Hansen AR, Stark AR. Manual of Neonatal Care. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012:304-309.
15. Flaherman VJ, Maisels MJ. ABM Clinical Protocol #22: Guidelines for management of jaundice in the breastfeeding infant 35 weeks or more of gestation-revised 2017. Breastfeed Med. 2017;12(5):250-257. DOI: https://doi.org/10.1089/bfm.2017.29042.vjf PMid:29624434
16. Riskin A, Tamir A, Kugelman A, Hemo M, Bader D. Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia? J Pediatr. 2008;152(6):782-787. DOI: https://doi.org/10.1016/j.jpeds.2007.11.003 PMid:18492516
17. Khurshid F, Rao SP, Sauve C, Gupta S. Universal screening for hyperbilirubinemia in term healthy newborns at discharge: A systematic review and meta-analysis. J Glob Health. 2022;12:12007. DOI: https://doi.org/10.7189/jogh.12.12007 PMid:36579719 PMCid:PMC9798347
18. Rosner B. Fundamentals of Biostatistics. 8th ed. Boston: Cengage Learning; 2016.
19. World Medical Association. Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-2194. DOI: https://doi.org/10.1001/jama.2013.281053 PMid:24141714
20. Nakagawa M, Ishida Y, Nagaoki Y, et al. Correlation between umbilical cord hemoglobin and rate of jaundice requiring phototherapy in healthy newborns. Pediatr Int. 2015;57(4):626-628. DOI: https://doi.org/10.1111/ped.12583 PMid:25533043
21. Gartner LM. Breastfeeding and jaundice. J Perinatol. 2001;21:S25-S29. DOI: https://doi.org/10.1038/sj.jp.7210629 PMid:11803412
22. Al Assal HM, Hablas HR, Ellatief Afia AA, Alhameed Khedr MA, Abd Elaal El kzaz HM. Utility of Cord Blood Alkaline Phosphatase Enzyme as a Predictor of Significant Neonatal Jaundice in Well Term Infants. New York Sci J. 2017;10(4):70-74.
23. Elgebaly S, Abdo M, et al. Cord blood alkaline phosphatase as a predictor of neonatal jaundice in full-term neonates. Zagazig Univ Med J. 2023;3016:29-306.
24. El-Amin DM, Ahmed YA, et al. Evaluation of cord blood alkaline phosphatase levels as an indicator of neonatal jaundice. Al-Amin Assiut Med J. 2020;18(2):112-117. DOI: https://doi.org/10.4103/AZMJ.AZMJ_92_19
25. Watchko JF. Hyperbilirubinemia and bilirubin toxicity in the late preterm infant. Clin Perinatol. 2006;33:839-852. DOI: https://doi.org/10.1016/j.clp.2006.09.002 PMid:17148008
26. Sally R, Eida M, et al. Evaluation of cord blood alkaline phosphatase as a predictor of hyperbilirubinemia in Egyptian neonates. J Arab Soc Med Res. 2020;15:11-17. DOI: https://doi.org/10.4103/jasmr.jasmr_30_19
27. Knupfer M, Pulzer F, et al. Predictive value of umbilical cord blood bilirubin for postnatal hyperbilirubinaemia. Acta Paediatr. 2005;94(5):581-587. DOI: https://doi.org/10.1111/j.1651-2227.2005.tb01943.x PMid:16188747
28. Okuyama H, et al. End-tidal carbon monoxide is predictive for neonatal non-hemolytic hyperbilirubinemia. Pediatr Int. 2001;43(6):329-333. DOI: https://doi.org/10.1046/j.1442-200X.2001.01412.x PMid:11472573
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Devyash Nagar , Prashant Shah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
